COSMOS Pharmaceutical Corporation (TYO:3349)
Japan · Delayed Price · Currency is JPY 5,995.00
-17.00 (-0.28%)
Jun 19, 2026, 3:30 PM JST
COSMOS Pharmaceutical Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, COSMOS Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ¥8,090. The average 1-year stock price forecast is 34.95% higher than the current stock price, while the lowest is ¥6,300 (+5.09%) and the highest is ¥9,750 (+62.64%).
Price Target: ¥8,090 (+34.95%)
Analyst Consensus: Buy
* Price targets were last updated on Dec 14, 2025.
Analyst Ratings
The average analyst rating for COSMOS Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 5 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Buy Upgrades ¥9,000 → ¥9,500 | Buy | Upgrades | ¥9,000 → ¥9,500 | +58.47% | Dec 14, 2025 |
Financial Forecast
Revenue This Year
1.09T
from 1.01T
Increased by 8.19%
Revenue Next Year
1.18T
from 1.09T
Increased by 7.55%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is JPY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.1T | ||
| Avg | 1.1T | ||
| Low | 1.1T |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.8% | ||
| Avg | 8.2% | ||
| Low | 6.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |
EPS Growth
| EPS Growth | 2027 | 2028 |
|---|---|---|
| High | - | |
| Avg | - | |
| Low | - |